Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Glancy Binkow & Goldberg Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit against Merge Healthcare Incorporated

Glancy Binkow & Goldberg LLPreminds investors that all purchasers of Merge Healthcare Incorporated (“Merge Healthcare” or the “Company”) (NASDAQ:MRGE) common stock between August 1, 2012 and January 7, 2014, inclusive (the “Class Period”), have until March 17, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit.

The Complaint filed in the United States District Court for the Northern District of Illinois alleges that the Company and certain of its executive officers and/or directors misrepresented or failed to disclose that, among other things:

  • The Company’s reported subscription backlog and its reported increase in backlog were false and overstated during the six quarters ended September 30, 2013.
  • The Company was experiencing a continued reluctance among large health systems to move forward with enterprise purchases.
  • The Company’s deficient internal controls resulted in the failure to properly log and verify customer contracts and appropriately calculate the commissions of its sales force.

If you purchased Merge Healthcare common stock during the Class Period, you may move the Court no later than March 17, 2014, to serve as lead plaintiff; however, you must meet certain legal requirements. To be a member of the Class, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Michael Goldberg, Esquire, of Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, California 90067, Toll-Free at (888) 773-9224, or contact Gregory Linkh, Esquire, of Glancy Binkow & Goldberg LLP at 122 E. 42nd Street, Suite 2920, New York, New York 10168, at (212) 682-5340, by e-mail to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.